Rapport Therapeutics: director Sanchez Ramiro bought 3,600 shares

What happened Sanchez Ramiro, a director of Rapport Therapeutics, bought 3,600 shares in open-market purchases on Oct 23, 2026 at a weighted average price of $27.35, for $98,478.

Key details

• Transaction date: Oct 23, 2026.
• Transaction code: P (purchase).
• Price: weighted average $27.35; purchases occurred at prices ranging from $27.07 to $27.47 (see footnote F1).
• Shares acquired: 3,600; total reported value $98,478.
• Shares owned after the transaction: not reported in this filing.
• Footnote F1: the Column 4 price is a weighted average; the reporting person will provide details of the number of shares purchased at each separate price upon request.
• Filing: Form filed on Oct 23, 2026 for the period of report Oct 23, 2026; the filing does not indicate it was late.

Why it may matter

• The filing reports an open-market purchase (code P).
• This was not reported as an option exercise, gift, award, or tax withholding.
  A filing does not show why the insider traded or why the company acted.